nodes	percent_of_prediction	percent_of_DWPC	metapath
Prilocaine—SCN3A—Interaction between L1 and Ankyrins—ANK3—attention deficit hyperactivity disorder	0.0519	0.13	CbGpPWpGaD
Prilocaine—SCN2A—Interaction between L1 and Ankyrins—ANK3—attention deficit hyperactivity disorder	0.0498	0.125	CbGpPWpGaD
Prilocaine—SCN1A—Interaction between L1 and Ankyrins—ANK3—attention deficit hyperactivity disorder	0.0481	0.121	CbGpPWpGaD
Prilocaine—SCN1A—forebrain—attention deficit hyperactivity disorder	0.0472	0.0846	CbGeAlD
Prilocaine—Diethylpropion—SLC6A3—attention deficit hyperactivity disorder	0.0435	1	CrCbGaD
Prilocaine—SCN2A—forebrain—attention deficit hyperactivity disorder	0.0434	0.0776	CbGeAlD
Prilocaine—SCN3A—forebrain—attention deficit hyperactivity disorder	0.0381	0.0682	CbGeAlD
Prilocaine—SCN5A—Interaction between L1 and Ankyrins—ANK3—attention deficit hyperactivity disorder	0.0338	0.0849	CbGpPWpGaD
Prilocaine—SCN5A—cardiovascular system—attention deficit hyperactivity disorder	0.0321	0.0575	CbGeAlD
Prilocaine—SCN1A—midbrain—attention deficit hyperactivity disorder	0.0312	0.0559	CbGeAlD
Prilocaine—SCN2A—midbrain—attention deficit hyperactivity disorder	0.0286	0.0513	CbGeAlD
Prilocaine—SCN1A—nervous system—attention deficit hyperactivity disorder	0.0256	0.0459	CbGeAlD
Prilocaine—SCN3A—midbrain—attention deficit hyperactivity disorder	0.0252	0.0451	CbGeAlD
Prilocaine—SCN1A—central nervous system—attention deficit hyperactivity disorder	0.0247	0.0442	CbGeAlD
Prilocaine—SCN1A—cerebellum—attention deficit hyperactivity disorder	0.0241	0.0432	CbGeAlD
Prilocaine—SCN2A—nervous system—attention deficit hyperactivity disorder	0.0235	0.0422	CbGeAlD
Prilocaine—SCN2A—central nervous system—attention deficit hyperactivity disorder	0.0227	0.0406	CbGeAlD
Prilocaine—SCN2A—cerebellum—attention deficit hyperactivity disorder	0.0222	0.0397	CbGeAlD
Prilocaine—SCN3A—nervous system—attention deficit hyperactivity disorder	0.0207	0.037	CbGeAlD
Prilocaine—SCN5A—nervous system—attention deficit hyperactivity disorder	0.0206	0.0369	CbGeAlD
Prilocaine—SCN3A—central nervous system—attention deficit hyperactivity disorder	0.0199	0.0357	CbGeAlD
Prilocaine—SCN3A—L1CAM interactions—ANK3—attention deficit hyperactivity disorder	0.0199	0.05	CbGpPWpGaD
Prilocaine—SCN5A—central nervous system—attention deficit hyperactivity disorder	0.0199	0.0356	CbGeAlD
Prilocaine—SCN1A—brain—attention deficit hyperactivity disorder	0.0196	0.0351	CbGeAlD
Prilocaine—SCN3A—cerebellum—attention deficit hyperactivity disorder	0.0195	0.0349	CbGeAlD
Prilocaine—SCN2A—L1CAM interactions—ANK3—attention deficit hyperactivity disorder	0.0191	0.0481	CbGpPWpGaD
Prilocaine—SCN1A—L1CAM interactions—ANK3—attention deficit hyperactivity disorder	0.0184	0.0463	CbGpPWpGaD
Prilocaine—SCN2A—brain—attention deficit hyperactivity disorder	0.018	0.0322	CbGeAlD
Prilocaine—SCN3A—brain—attention deficit hyperactivity disorder	0.0158	0.0283	CbGeAlD
Prilocaine—SCN5A—brain—attention deficit hyperactivity disorder	0.0158	0.0282	CbGeAlD
Prilocaine—SCN5A—L1CAM interactions—ANK3—attention deficit hyperactivity disorder	0.013	0.0326	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00752	0.0189	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00723	0.0182	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00697	0.0175	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.0062	0.0156	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00537	0.0135	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00533	0.0134	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.0053	0.0133	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00516	0.013	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00509	0.0128	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00497	0.0125	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00495	0.0124	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00495	0.0124	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00491	0.0123	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.0049	0.0123	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00485	0.0122	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00466	0.0117	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00449	0.0113	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00378	0.0095	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00373	0.00936	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00363	0.00913	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.0036	0.00903	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.0035	0.0088	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.0035	0.00878	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00346	0.00869	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00345	0.00867	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00332	0.00835	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00321	0.00805	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00316	0.00793	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00304	0.00763	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00246	0.00619	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00225	0.00566	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.00161	0.00404	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000983	0.00247	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000944	0.00237	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000911	0.00229	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.00064	0.00161	CbGpPWpGaD
